Feeds › Ownership stakes (13D / 13G)
Ownership stakes (13D / 13G)
Investors who own more than 5% of a company, from activists (13D) to passive holders (13G).
About this data
- What it is
- An investor who owns more than 5% of a public company must say so. Investors who may try to influence the company, such as activists, file the longer Schedule 13D; passive holders file the shorter Schedule 13G.
- Who files it
- The investor, within days of crossing 5%, and again whenever the stake changes materially.
- How current
- We collect new filings throughout the day on SEC business days.
- Worth knowing
- 13G filings are far more common than 13D. A 13D usually means the investor intends to push for changes, so it tends to get more attention.
All of this comes from public filings.
Source and freshness · Information, not investment advice (disclaimer).
Filings per day, last 30 days
13D (activist) 13G (passive)
Latest ownership filings
Showing: ticker DLB
| Filed | ScheduleBoth report a stake of more than 5%. A 13D is filed by investors who may try to influence the company, such as activists; a 13G by passive holders. | Company | Investor | Shares | % of shares | Filing |
|---|---|---|---|---|---|---|
| Nov 13, 2026 | SCHEDULE 13G/A (amended) | DLB Dolby Laboratories | Atlanta Capital Management Company, LLC | 2.10M | 3.5% | SCHEDULE 13G/A ↗ |
| Nov 13, 2026 | SCHEDULE 13G/A (amended) | DLB Dolby Laboratories | Morgan Stanley | 3.04M | 5.1% | SCHEDULE 13G/A ↗ |
| Oct 27, 2026 | SCHEDULE 13G | DLB Dolby Laboratories | The Charger Corporation | 3.02M | 5.1% | SCHEDULE 13G ↗ |
| Oct 27, 2026 | SCHEDULE 13G | DLB Dolby Laboratories | First Trust Advisors L.P. | 3.02M | 5.1% | SCHEDULE 13G ↗ |
| Oct 27, 2026 | SCHEDULE 13G | DLB Dolby Laboratories | First Trust Portfolios L.P. | 3.02M | 5.1% | SCHEDULE 13G ↗ |
| Oct 22, 2026 | SCHEDULE 13G/A (amended) | DLB Dolby Laboratories | Newton Investment Management North America, LLC | 3.93M | 6.6% | SCHEDULE 13G/A ↗ |
| Oct 22, 2026 | SCHEDULE 13G/A (amended) | DLB Dolby Laboratories | MBC Investments Corp | 4.43M | 7.5% | SCHEDULE 13G/A ↗ |
| Oct 22, 2026 | SCHEDULE 13G/A (amended) | DLB Dolby Laboratories | BNY Mellon IHC, LLC | 4.43M | 7.5% | SCHEDULE 13G/A ↗ |
| Oct 22, 2026 | SCHEDULE 13G/A (amended) | DLB Dolby Laboratories | Bank of New York Mellon Corp | 5.12M | 8.6% | SCHEDULE 13G/A ↗ |
| Jun 4, 2026 | SCHEDULE 13G/A (amended) | DLB Dolby Laboratories | BlackRock, Inc. | 6.04M | 10.0% | SCHEDULE 13G/A ↗ |
| May 11, 2026 | SCHEDULE 13G/A (amended) | DLB Dolby Laboratories | Atlanta Capital Management Company, LLC | 3.93M | 6.4% | SCHEDULE 13G/A ↗ |
| May 11, 2026 | SCHEDULE 13G/A (amended) | DLB Dolby Laboratories | Morgan Stanley | 5.02M | 8.2% | SCHEDULE 13G/A ↗ |
| Apr 29, 2026 | SCHEDULE 13G | DLB Dolby Laboratories | Vanguard Portfolio Management | 5.02M | 8.2% | SCHEDULE 13G ↗ |
| Apr 29, 2026 | SCHEDULE 13G | DLB Dolby Laboratories | Vanguard Capital Management | 3.19M | 5.2% | SCHEDULE 13G ↗ |
| Apr 28, 2026 | SCHEDULE 13G/A (amended) | DLB Dolby Laboratories | Newton Investment Management North America, LLC | 3.28M | 5.4% | SCHEDULE 13G/A ↗ |
| Apr 28, 2026 | SCHEDULE 13G/A (amended) | DLB Dolby Laboratories | MBC Investments Corp | 3.79M | 6.2% | SCHEDULE 13G/A ↗ |
| Apr 28, 2026 | SCHEDULE 13G/A (amended) | DLB Dolby Laboratories | BNY Mellon IHC, LLC | 3.79M | 6.2% | SCHEDULE 13G/A ↗ |
| Apr 28, 2026 | SCHEDULE 13G/A (amended) | DLB Dolby Laboratories | Bank of New York Mellon Corp | 4.50M | 7.4% | SCHEDULE 13G/A ↗ |
| Mar 26, 2026 | SCHEDULE 13G/A (amended) | DLB Dolby Laboratories | The Vanguard Group | 0 | 0.0% | SCHEDULE 13G/A ↗ |
| Feb 13, 2026 | SCHEDULE 13D/A (amended) | DLB Dolby Laboratories | David E. Dolby | 33.62M | 35.2% | SCHEDULE 13D/A ↗ |
| Feb 13, 2026 | SCHEDULE 13D/A (amended) | DLB Dolby Laboratories | Thomas E. Dolby | 680,592 | 0.7% | SCHEDULE 13D/A ↗ |
| Feb 13, 2026 | SCHEDULE 13D/A (amended) | DLB Dolby Laboratories | Dagmar Dolby, as Trustee of the Dagmar Dolby 2016 Trust B dated March 23, 2016 | 403,600 | 0.4% | SCHEDULE 13D/A ↗ |
| Feb 13, 2026 | SCHEDULE 13D/A (amended) | DLB Dolby Laboratories | Dolby Holdings III LLC | 350,000 | 0.4% | SCHEDULE 13D/A ↗ |
| Feb 13, 2026 | SCHEDULE 13D/A (amended) | DLB Dolby Laboratories | Dolby Holdings II LLC | 1.04M | 1.1% | SCHEDULE 13D/A ↗ |
| Feb 13, 2026 | SCHEDULE 13D/A (amended) | DLB Dolby Laboratories | Dagmar Dolby, as Trustee of the Ray Dolby 2002 Trust B dated April 19, 2002 | 463,262 | 0.5% | SCHEDULE 13D/A ↗ |
| Feb 13, 2026 | SCHEDULE 13D/A (amended) | DLB Dolby Laboratories | Dagmar Dolby, as Trustee of the Ray Dolby 2002 Trust A dated April 19, 2002 | 160,592 | 0.2% | SCHEDULE 13D/A ↗ |
| Feb 13, 2026 | SCHEDULE 13D/A (amended) | DLB Dolby Laboratories | Dagmar Dolby, as Trustee of the Dagmar Dolby Trust under the Dolby Family Trust Instrument dated May 7, 1999 | 7.68M | 8.0% | SCHEDULE 13D/A ↗ |
| Feb 13, 2026 | SCHEDULE 13D/A (amended) | DLB Dolby Laboratories | Dagmar Dolby, as Trustee of the Marital Trust under the Dolby Family Trust Instrument dated May 7, 1999 | 24.11M | 25.2% | SCHEDULE 13D/A ↗ |
| Feb 13, 2026 | SCHEDULE 13D/A (amended) | DLB Dolby Laboratories | Dagmar Dolby | 34.37M | 36.0% | SCHEDULE 13D/A ↗ |
| Feb 11, 2026 | SCHEDULE 13G/A (amended) | DLB Dolby Laboratories | Eaton Vance Atlanta Capital SMID-Cap Fund | 3.97M | 6.5% | SCHEDULE 13G/A ↗ |
| Feb 11, 2026 | SCHEDULE 13G/A (amended) | DLB Dolby Laboratories | Atlanta Capital Management Company, LLC | 5.23M | 8.6% | SCHEDULE 13G/A ↗ |
| Feb 11, 2026 | SCHEDULE 13G/A (amended) | DLB Dolby Laboratories | Morgan Stanley | 6.19M | 10.2% | SCHEDULE 13G/A ↗ |
| Apr 30, 2025 | SCHEDULE 13G/A (amended) | DLB Dolby Laboratories | The Vanguard Group | 7.54M | 12.3% | SCHEDULE 13G/A ↗ |
| Apr 21, 2025 | SCHEDULE 13G/A (amended) | DLB Dolby Laboratories | Newton Investment Management North America, LLC | 4.19M | 6.9% | SCHEDULE 13G/A ↗ |
| Apr 21, 2025 | SCHEDULE 13G/A (amended) | DLB Dolby Laboratories | MBC Investments Corp | 4.81M | 7.9% | SCHEDULE 13G/A ↗ |
| Apr 21, 2025 | SCHEDULE 13G/A (amended) | DLB Dolby Laboratories | BNY Mellon IHC, LLC | 4.81M | 7.9% | SCHEDULE 13G/A ↗ |
| Apr 21, 2025 | SCHEDULE 13G/A (amended) | DLB Dolby Laboratories | Bank of New York Mellon Corp | 5.71M | 9.3% | SCHEDULE 13G/A ↗ |
| Feb 3, 2025 | SCHEDULE 13D/A (amended) | DLB Dolby Laboratories | David E. Dolby | 34.50M | 35.8% | SCHEDULE 13D/A ↗ |
| Feb 3, 2025 | SCHEDULE 13D/A (amended) | DLB Dolby Laboratories | Thomas E. Dolby | 680,592 | 0.7% | SCHEDULE 13D/A ↗ |
| Feb 3, 2025 | SCHEDULE 13D/A (amended) | DLB Dolby Laboratories | Dagmar Dolby, as Trustee of the Dagmar Dolby 2016 Trust B dated March 23, 2016 | 403,600 | 0.4% | SCHEDULE 13D/A ↗ |
| Feb 3, 2025 | SCHEDULE 13D/A (amended) | DLB Dolby Laboratories | Dolby Holdings III LLC | 350,000 | 0.4% | SCHEDULE 13D/A ↗ |
| Feb 3, 2025 | SCHEDULE 13D/A (amended) | DLB Dolby Laboratories | Dolby Holdings II LLC | 1.04M | 1.1% | SCHEDULE 13D/A ↗ |
| Feb 3, 2025 | SCHEDULE 13D/A (amended) | DLB Dolby Laboratories | Dagmar Dolby, as Trustee of the Ray Dolby 2002 Trust B dated April 19, 2002 | 463,262 | 0.5% | SCHEDULE 13D/A ↗ |
| Feb 3, 2025 | SCHEDULE 13D/A (amended) | DLB Dolby Laboratories | Dagmar Dolby, as Trustee of the Ray Dolby 2002 Trust A dated April 19, 2002 | 160,592 | 0.2% | SCHEDULE 13D/A ↗ |
| Feb 3, 2025 | SCHEDULE 13D/A (amended) | DLB Dolby Laboratories | Dagmar Dolby, as Trustee of the Dagmar Dolby Trust under the Dolby Family Trust Instrument dated May 7, 1999 | 8.57M | 8.9% | SCHEDULE 13D/A ↗ |
| Feb 3, 2025 | SCHEDULE 13D/A (amended) | DLB Dolby Laboratories | Dagmar Dolby, as Trustee of the Marital Trust under the Dolby Family Trust Instrument dated May 7, 1999 | 24.11M | 25.0% | SCHEDULE 13D/A ↗ |
| Feb 3, 2025 | SCHEDULE 13D/A (amended) | DLB Dolby Laboratories | Dagmar Dolby | 35.30M | 36.6% | SCHEDULE 13D/A ↗ |
| Jan 23, 2025 | SCHEDULE 13G | DLB Dolby Laboratories | Newton Investment Management North America, LLC | 3.99M | 6.6% | SCHEDULE 13G ↗ |
| Jan 23, 2025 | SCHEDULE 13G | DLB Dolby Laboratories | MBC Investments Corp | 4.55M | 7.5% | SCHEDULE 13G ↗ |
| Jan 23, 2025 | SCHEDULE 13G | DLB Dolby Laboratories | BNY Mellon IHC, LLC | 4.55M | 7.5% | SCHEDULE 13G ↗ |
Full history on every feed is part of Premium. Premium loads older rows, up to 10,000, and CSV downloads.
The newest 50 items, most recent first. Every row links to its original filing. Updated Nov 15, 2026, 6:42 PM EST.
Download CSV The rows of this feed, with the filters above. A download holds at most 10,000 rows; narrow the filters to get a smaller slice.
Other feeds: Congressional trades · Executive-branch trades · Bills in Congress · Roll-call votes · Corporate PAC donations · Lobbying · Capitol Hires · Lobbying and contracts · Government contracts · Insider trades · Planned insider sales · Executive pay · Institutional holdings (13F) · Short interest · Fails to deliver · Daily short volume · Wikipedia page views · App store ratings · H-1B visa applications · Stock splits · 8-K events · IPO filings · Deals · Private placements (Form D) · Merger clearances (HSR) · Layoff notices (WARN) · SEC enforcement · Patents · Clinical trial updates · FDA approvals and clearances